StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) income statement

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3029% below fair value
$4.53+0.09 (+2.03%)

Close on Nov 18, 2026Market cap $294.61MP/E –Yield –

Treace Medical Concepts, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
79.5%
Operating margin
-26.2%
Net margin
-29.0%
Return on equity, FY2025
-58.9%

Financial strength

Current ratio
2.90
Debt to equity
0.87
Debt to assets
32.7%
Cash to current liabilities
30.4%

Valuation

P/E ratio
–
Price to sales
1.43
Price to book
4.35
Dividend yield
–

See a number that looks wrong?